Drugs / DPS-102
last change Apr 2014 re-read 2 minutes ago

DPS-102

Developed for
psoriasis
Investigated by
DermiPsor, Ltd.

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01368887 Apr → Nov 2013 psoriasis DermiPsor, Ltd. Suspended No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DPS-102 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01368887